查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
微生物治疗市场规模、市场份额、应用分析、区域展望、增长趋势、主要参与者、竞争战略、预测，2023-2031 年
市场调查报告书
商品编码
1283954

微生物治疗市场规模、市场份额、应用分析、区域展望、增长趋势、主要参与者、竞争战略、预测，2023-2031 年

Microbiome Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031
出版日期: | 出版商: Acute Market Reports | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

到 2031 年，微生物组疗法市场预计将增长 32%。 微生物组疗法市场是当今世界充满机遇的新兴市场。 市场专家指出，预测期内参与临床试验的产品数量证明，以微生物组疗法为重点的研发活动正在世界各地开展。 鑑于微生物组市场的结构，潜力巨大。 支持这个市场增长的主要因素是老年人口的增长、与生活方式相关的疾病的流行以及对高效和副作用少的治疗的需求增加。 另一方面，制约市场增长的主要因素是市场开发缺乏广泛的研究，公众对益生元和益生菌的有效使用和效果的认识低下，其中包括政府即将对益生元进行监管。 微生物组市场细分包括药物类型、疾病和地区。

据市场专家称，自 2010 年以来，人类微生物环境吸引了超过 6.5 亿美元的投资。 近年来，益生菌或有益的肠道微生物疗法越来越受欢迎。 这些产品能够通过将人体微生物组恢復到自然状态来预防许多疾病。 然而，微生物组疗法的整体市场仍处于起步阶段，不能用作药物的替代品或作为根除疾病的治疗方法。 按地区划分，欧洲有望成为最大的微生物疗法市场，其次是北美。 支持欧洲微生物组治疗市场的一个主要因素似乎是对益生菌和益生元产品的高度接受和日益增长的认识。 就预测期内的人口和疾病流行而言，亚太地区被确认为最具潜力的地区。

内容

第一章前言

  • 报告内容
    • 报告的目的
    • 目标受众
    • 主要产品
  • 市场细分
  • 调查方法
    • 第一阶段 - 二次调查
    • 第二阶段 - 初步调查
    • 第三阶段 - 专家评审
    • 先决条件
    • 采用的方法

第 2 章执行摘要

  • 市场概况：微生物组疗法的全球市场
  • 2022 年按类型划分的全球微生物组治疗市场
  • 2022 年按应用划分的全球微生物组治疗市场
  • 2022 年按地区划分的全球微生物组治疗市场
  • 有吸引力的投资建议：按地区划分，2022 年

第 3 章微生物治疗市场：竞争分析

  • 主要供应商的市场定位
  • 供应商采用的策略
  • 主要产业战略
  • 等级分析：2022 年与 2031 年

第 4 章微生物组治疗市场：宏观分析和市场动态

  • 简介
  • 2021-2031 年全球微生物组疗法的市场价值
  • 市场动态
    • 市场驱动因素
    • 市场製约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

第 5 章微生物组治疗市场，按类型：2021-2031

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • 裂变材料
    • 微生物医学

第 6 章微生物组治疗市场，按应用：2021-2031

  • 市场概览
  • 增长和收益分析：2022 年与 2031 年
  • 市场细分
    • 艰难梭菌
    • 克罗恩病
    • 炎症性肠病
    • 糖尿病
    • 其他

第 7 章北美微生物组治疗市场：2021-2031

  • 市场概览
  • 微生物组治疗市场，按类型：2021-2031
  • 微生物组治疗市场，按应用划分：2021-2031 年
  • 按地区划分的微生物组治疗市场：2021-2031 年
    • 北美
      • 美国
      • 加拿大
      • 其他北美地区

第 8 章英国和欧盟微生物组治疗市场：2021-2031

  • 市场概览
  • 微生物组治疗市场，按类型：2021-2031
  • 微生物组治疗市场，按应用划分：2021-2031 年
  • 按地区划分的微生物组治疗市场：2021-2031 年
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 其他欧洲地区

第 9 章亚太微生物组治疗市场：2021-2031

  • 市场概览
  • 微生物组治疗市场，按类型：2021-2031
  • 微生物组治疗市场，按应用划分：2021-2031 年
  • 按地区划分的微生物组治疗市场：2021-2031 年
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区

第 10 章拉丁美洲微生物组治疗市场：2021-2031

  • 市场概览
  • 微生物组治疗市场，按类型：2021-2031
  • 微生物组治疗市场，按应用划分：2021-2031 年
  • 按地区划分的微生物组治疗市场：2021-2031 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第 11 章中东和非洲微生物组治疗市场：2021-2031

  • 市场概览
  • 微生物组治疗市场，按类型：2021-2031
  • 微生物组治疗市场，按应用划分：2021-2031 年
  • 按地区划分的微生物组治疗市场：2021-2031 年
    • 中东和非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东和非洲地区

第12章公司简介

  • OpenBiome
  • Seres Therapeutics Inc.
  • 4D Pharma plc.
  • Locus Biosciences Inc.
  • Enterome SA
  • Finch Therapeutics Group Inc.
  • Intralytix Inc.
  • Microbiotica
  • Second Genome
  • Rebiotix Inc.
  • Vedanta Bioscience Inc.
  • 其他企业
Product Code: 136931-05-23

Microbiome Therapeutics Market is Expected to Grow at 32% by 2031. Microbiome therapeutics market is an emerging market with abundant opportunities in today's world. During the forecast period market experts suggest that number of products currently involved in clinical trials proves the amount of research and development activities carried out across the world focusing on microbiome therapeutics. Considering the structure of the microbiome market the potential is quite large. The key factors assisting the growth of this market comprise rising geriatric population, increasing incidences of lifestyle diseases, increasing demand for treatments with high efficiency and low side effects. The major factors that are expected to restrain the growth of this market are lack of broad research to aid the market pull, low awareness among the population related to the efficient usage and effect of prebiotics and probiotics, and impending government regulations on probiotics and prebiotics. The segmentation of microbiome market comprises of type of drugs, diseases, and geography.

Market experts suggest that the microbial landscape of human body has attracted more than US$ 650 Mn since 2010. In recent years, probiotics, or beneficial gut bacteria therapy, have been popular. These products possess capacity of preventing number of diseases by restoring the human microbiome to its natural state. However, the overall microbiome therapeutics market is still in its infancy; hence, cannot be used as a replacement for medication or as a treatment for the eradication of the disease. Europe was observed as the leading regional market for microbiome therapeutics followed by North America. The key factors assisting the microbiome therapeutics market in Europe are due to high acceptance and rising awareness of probiotic and prebiotic products. Asia-Pacific was observed as the most potential region in terms of population and prevalence of disease throughout the forecast period.

Key Players Identified for Microbiome Therapeutics Market Include but are Not Limited to:

OpenBiome, Seres Therapeutics Inc., 4D Pharma plc., Locus Biosciences, Inc., Enterome SA, Finch Therapeutics Group, Inc., Intralytix, Inc., Microbiotica, Second Genome, Rebiotix Inc., Vedanta Bioscience, Inc. And Other Notable Players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Microbiome Therapeutics market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Microbiome Therapeutics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

  • FMT
  • Microbiome Drugs

Application

  • C. difficile
  • Crohn's disease
  • Inflammatory Bowel Disease
  • Diabetes
  • Others

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Microbiome Therapeutics market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Microbiome Therapeutics market?
  • Which is the largest regional market for Microbiome Therapeutics market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Microbiome Therapeutics market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Microbiome Therapeutics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Microbiome Therapeutics Market
  • 2.2. Global Microbiome Therapeutics Market, By Type, 2022 (US$ Million)
  • 2.3. Global Microbiome Therapeutics Market, By Application, 2022 (US$ Million)
  • 2.4. Global Microbiome Therapeutics Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Microbiome Therapeutics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Microbiome Therapeutics Market Vendors
  • 3.2. Strategies Adopted by Microbiome Therapeutics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Microbiome Therapeutics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Microbiome Therapeutics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. FMT
    • 5.3.2. Microbiome Drugs

6. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. C. difficile
    • 6.3.2. Crohn's disease
    • 6.3.3. Inflammatory Bowel Disease
    • 6.3.4. Diabetes
    • 6.3.5. Others

7. North America Microbiome Therapeutics Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
  • 7.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 7.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 7.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)

8. UK and European Union Microbiome Therapeutics Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
  • 8.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 8.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.4.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.5.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 8.4.1.6.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)

9. Asia Pacific Microbiome Therapeutics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
  • 9.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 9.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.4.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.5.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 9.4.1.6.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)

10. Latin America Microbiome Therapeutics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
  • 10.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 10.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 10.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)

11. Middle East and Africa Microbiome Therapeutics Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
  • 11.3. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
  • 11.4.Microbiome Therapeutics Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.1.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.2.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Microbiome Therapeutics Market: By Type, 2021-2031, USD (Million)
        • 11.4.1.3.1. Microbiome Therapeutics Market: By Application, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. OpenBiome
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Seres Therapeutics Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. 4D Pharma plc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Locus Biosciences, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Enterome SA
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Finch Therapeutics Group, Inc.
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Intralytix, Inc.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Microbiotica
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Second Genome
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Rebiotix Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Vedanta Bioscience, Inc.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
  • 12.12. Other Notable Players
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Portfolio
    • 12.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 3 North America Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 4 North America Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 5 U.S. Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 6 U.S. Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 7 Canada Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 8 Canada Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 9 Rest of North America Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 10 Rest of North America Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 11 UK and European Union Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 12 UK and European Union Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 13 UK Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 14 UK Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 15 Germany Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 16 Germany Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 17 Spain Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 18 Spain Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 19 Italy Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 20 Italy Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 21 France Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 22 France Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 23 Rest of Europe Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 24 Rest of Europe Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 25 Asia Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 26 Asia Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 27 China Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 28 China Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 29 Japan Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 30 Japan Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 31 India Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 32 India Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 33 Australia Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 34 Australia Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 35 South Korea Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 36 South Korea Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 37 Latin America Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 38 Latin America Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 39 Brazil Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 40 Brazil Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 41 Mexico Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 42 Mexico Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 43 Rest of Latin America Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 44 Rest of Latin America Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Middle East and Africa Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 46 Middle East and Africa Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 47 GCC Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 48 GCC Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 49 Africa Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 50 Africa Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Microbiome Therapeutics Market By Type, 2021-2031, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Microbiome Therapeutics Market By Application, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Microbiome Therapeutics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Microbiome Therapeutics Market: Quality Assurance
  • FIG. 5 Global Microbiome Therapeutics Market, By Type, 2022
  • FIG. 6 Global Microbiome Therapeutics Market, By Application, 2022
  • FIG. 7 Global Microbiome Therapeutics Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Microbiome Therapeutics Market, 2022
  • FIG. 9 Market Positioning of Key Microbiome Therapeutics Market Players, 2022
  • FIG. 10 Global Microbiome Therapeutics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 11 Global Microbiome Therapeutics Market, By Type, 2022 Vs 2031, %
  • FIG. 12 Global Microbiome Therapeutics Market, By Application, 2022 Vs 2031, %
  • FIG. 13 U.S. Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 20 France Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 22 China Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 24 India Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Microbiome Therapeutics Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Microbiome Therapeutics Market (US$ Million), 2021 - 2031